Search company, investor...

Archus Orthopedics

archusorthopedics.com

Founded Year

2001

Stage

Dead | Dead

Total Raised

$71.55M

About Archus Orthopedics

TFAS is a spinal implant indicated for the treatment of patients with chronic back pain and/or leg pain caused by spinal stenosis. It is designed to stabilize and reinforce your spine after removal of bone and/or tissue that is pressing on your nerves and causing pain. This innovative device offer a potential alternative to rigid spinal fusion surgery.

Headquarters Location

8624 154th Avenue NE

Redmond, Washington, 98052,

United States

425-869-2100

Missing: Archus Orthopedics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Archus Orthopedics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Archus Orthopedics Patents

Archus Orthopedics has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/25/2004

10/27/2009

Bones of the vertebral column, Skeletal system, Spinal nerves, Spinal cord, Vertebrate anatomy

Grant

Application Date

10/25/2004

Grant Date

10/27/2009

Title

Related Topics

Bones of the vertebral column, Skeletal system, Spinal nerves, Spinal cord, Vertebrate anatomy

Status

Grant

Latest Archus Orthopedics News

Archus Orthopedics, Spine Device Maker that Raised $60M, Shuts Down Amid Cash Crunch

Sep 21, 2015

Seattle Archus Orthopedics, the Redmond, WA-based developer of implants to help people retain flexibility after back surgery , is shutting down its operations and dissolving after it was unable to raise enough capital to bring the product all the way to the U.S. market, Xconomy has learned. Archus filed paperwork with the Delaware Secretary of State to dissolve the company and wind down the business, according to a legal notice on The Seattle Times website. Archus CEO Jim Fitzsimmons, reached by phone, said he had no comment. We broke the story back in May about financial troubles at Archus , which had been one of the rising stars in the Seattle medical device industry for years. The company had a veteran medical device entrepreneur in Fitzsimmons as CEO, and raised more than $63 million in equity since its founding 2001 from a group of big-name venture firms—MPM Capital, InterWest Partners, Polaris Venture Partners, and Johnson & Johnson Development Corporation, as well as a loan from GE Capital. Cash ran low this spring when Archus was sponsoring a big clinical trial of 450 patients, and it was forced to lay off most of its 45 employees. In the last few months, it tried to find a partner or some other way to finish the clinical trials it needed to start marketing its experimental device. “Although Archus Orthopedics has been performing very well, we have the unfortunate luck to be a relatively mature, but still pre-revenue company, in need [of] sustaining capital in an extremely challenging financing market,” Fitzsimmons said in a statement back in May. Archus had been developing artificial facet (fuh-set) joints in the spine, with a technology called the Total Facet Arthroplasty System. These facet joints—not to be confused with artificial spinal discs—play a role every time we bend forward, bend backward, or twist laterally. These joints typically get fused together when people have back surgery, because conventional wisdom says cutting down movement will reduce the pain. It also greatly cuts down on people’s mobility, and puts extra pressure and twisting movements on the non-fused parts of the spine, Fitzsimmons said. One patient who received an Archus implant, Larry Kirschner of Baton Rouge, LA, said he was disappointed to hear of the dissolution because his device worked “superbly.” Kirschner, a 62-year-old microbiologist, had his surgery in May 2006. Six weeks later, he helped load a moving truck and drove it more than 1,600 miles from Pasadena, CA to Baton Rouge. Last year, he felt good enough to go on a snowshoeing and camping trip above 9,000 feet in the Sierra Nevada mountains. “The Archus device freed me from the vast majority of the debilitating pain I was experiencing (there is still a small spot on my right shin that aches a little from time to time, but nothing significant),” Kirschner wrote in an e-mail. “I haven’t started in-line skating again but may this winter when things cool off around here.” More from EXOME

Archus Orthopedics Frequently Asked Questions (FAQ)

  • When was Archus Orthopedics founded?

    Archus Orthopedics was founded in 2001.

  • Where is Archus Orthopedics's headquarters?

    Archus Orthopedics's headquarters is located at 8624 154th Avenue NE, Redmond.

  • What is Archus Orthopedics's latest funding round?

    Archus Orthopedics's latest funding round is Dead.

  • How much did Archus Orthopedics raise?

    Archus Orthopedics raised a total of $71.55M.

  • Who are the investors of Archus Orthopedics?

    Investors of Archus Orthopedics include GE Healthcare, MPM Capital, Polaris Partners, InterWest Partners, Johnson & Johnson Innovation and 4 more.

  • Who are Archus Orthopedics's competitors?

    Competitors of Archus Orthopedics include NICO, Biorez, MicroTransponder, Spineology, BioWave, MedShape, Relievant Medsystems, Mimedx, Flowonix Medical, CSA Medical and 81 more.

Compare Archus Orthopedics to Competitors

R
Ranier Technology

CAdisc is a unique, entirely polymeric Total Disc Replacement system for the treatment of degenerative disc disease in the lumbar and cervical spine. CAdisc-Lchar(2122) is designed to relieve pain and restore physiological quality of motion in the lumbar spine.

G
Gentis

Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine, which causes back pain. The company's first patented product, DiscCell, is a breakthrough injectable biomaterial that augments or replaces the diseased nucleus pulposus of the spinal disc.

BioWave Logo
BioWave

BioWave is a neuromodulation pain therapy company whose major goal is to help physicians, physical therapists and athletic trainers manage their patients' or athletes pain and reduce or eliminate the use of opiates, NSAIDs and their associated side effects. Biowave devices deliver a therapeutic electrical signal into deep tissue in the body blocking the transmission of pain.

F
Facet Solutions

Facet Solutions has developed a total replacement for the facet joint to treat back pain from hypertrophy.

I
Interventional Spine

Interventional Spine, fka Triage Medical, is a medical device company focused on the design, development, and marketing of patented percutaneous systems to treat lower back pain. Interventional Spine's expandable cage technology provides optimal tactile feedback for the surgeon, and features a continuously adjustable design that allows the surgeon to customize the device height to the patient's anatomy. The implants are designed to maximize bone graft contact and containment, which helps promote bone growth and fusion. The company was founded in 2000 and is based in Irvine, California.

A
AllTranz

AllTranz aims to provide relief from chronic pain to patients outside the hospital setting.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.